The National Forum submitted to the Institute for Clinical and Economic Review (ICER) feedback from the Value & Access Steering Committee and partners on ICER’s Draft Evidence Report on Additive Cardiovascular Disease Therapies. The feedback reflects the consensus of Value & Access Steering Committee members and partners who represent patients, clinical providers, payers and public health.
View the document